Ann Gen Psychiatry. 2011 Apr 24;10:15. doi: 10.1186/1744-859X-10-15.
Advanced paternal age is a risk factor for schizophrenia in Iranians.
Annals of general psychiatry
Morteza Naserbakht, Hamid-Reza Ahmadkhaniha, Bahareh Mokri, Cassandra L Smith
PMID: 21513574
PMCID: PMC3094249 DOI: 10.1186/1744-859X-10-15
Abstract
BACKGROUND: Since 1958 many, but not all studies have demonstrated that paternal age is a risk factor for schizophrenia. There may be many different explanations for differences between studies, including study design, sample size, collection criteria, heterogeneity and the confounding effects of environmental factors that can for example perturb epigenetic programming and lead to an increase in disease risk. The small number of children in Western families makes risk comparisons between siblings born at different paternal ages difficult. In contrast, more Eastern families have children both at early and later periods of life. In the present study, a cross-sectional population study in an Iranian population was performed to compare frequency of schizophrenia in younger offspring (that is, older paternal age) versus older offspring.
METHODS: A total of 220 patients with the diagnosis of schizophrenia (cases) from both psychiatric hospitals and private clinics and 220 individuals from other hospital wards (controls), matched for sex and age were recruited for this study. Patients with neurological problem, substance abuse, mental retardation and mood disorder were excluded from both groups.
RESULTS: Birth rank comparisons revealed that 35% vs 24% of the cases vs the controls were in the third or upper birth rank (P = 0.01). Also, the mean age of fathers at birth in case group (30 ± 6.26 years) was significantly more than the control group (26.45 ± 5.64 years; P = 0.0001). The age of 76 fathers at birth in case group was over 32 versus 33 fathers in control group. Individuals whose fathers' age was more than 32 (at birth) were at higher risk (2.77 times) for schizophrenia versus others (P < 0.0001, 95% CI 1.80 to 4.27). The maternal age at parturition of the case versus controls groups was 26.1 ± 5.41 vs 25.07 ± 4.47 (P = 0.02). Logistic regression analysis suggests that maternal age is less likely to be involved in the higher risk of schizophrenia than advanced parental age.
DISCUSSION: This study demonstrates a relationship between paternal age and schizophrenia in large families of an Iranian population. Arguments have been put forth that DNA bases changes or epigenetic changes in sperm account for the increased risk associated with older fathers. However, it would not be surprising that both de novo germline mutations and epigenetic changes contribute to disease occurrence because DNA replication and DNA methylation are closely linked at both the macromolecular level (that is, methylation closely follows replication), and at the metabolic level (both processes require folate), and susceptible to modulation by the environment. Further research on samples such as those collected here are needed to sort out the contributions of de novo mutations versus epigenetic changes to schizophrenia.
References
- Psychiatry Res. 2007 Mar 30;150(2):205-10 - PubMed
- Am J Epidemiol. 1999 Dec 1;150(11):1208-12 - PubMed
- BMJ. 2004 Nov 6;329(7474):1070 - PubMed
- Novartis Found Symp. 2008;289:196-203; discussion 203-7, 238-40 - PubMed
- J Natl Med Assoc. 2006 Jan;98(1):67-72 - PubMed
- Am J Med Genet B Neuropsychiatr Genet. 2004 May 15;127B(1):51-9 - PubMed
- Brain Dev. 2001 Dec;23 Suppl 1:S186-90 - PubMed
- Prog Neuropsychopharmacol Biol Psychiatry. 2004 Aug;28(5):753-62 - PubMed
- Lancet. 1998 Jul 18;352(9123):204 - PubMed
- Am J Pharmacogenomics. 2005;5(3):149-60 - PubMed
- Acta Med Iran. 1977;19(2):155-66 - PubMed
- Schizophr Res. 1997 Nov 7;28(1):1-38 - PubMed
- Arch Gen Psychiatry. 1989 Oct;46(10):873-7 - PubMed
- Br J Psychiatry. 1988 Apr;152:482-6 - PubMed
- Arch Gen Psychiatry. 2003 Jul;60(7):673-8 - PubMed
- Schizophr Bull. 2001;27(3):379-93 - PubMed
- Biol Psychiatry. 2004 May 15;55(10):965-70 - PubMed
- BMC Psychiatry. 2008 Aug 21;8:71 - PubMed
- Schizophr Res. 1999 Nov 9;40(1):43-7 - PubMed
- Mol Psychiatry. 2007 Jun;12(6):519, 593-600 - PubMed
- Arch Gen Psychiatry. 2008 Feb;65(2):146-52 - PubMed
- World J Biol Psychiatry. 2000 Jan;1(1):35-41 - PubMed
- Am J Med Genet. 2002 Apr 8;114(3):299-303 - PubMed
- J Am Diet Assoc. 2007 Jul;107(7):1113-23 - PubMed
- Am J Psychiatry. 2002 Sep;159(9):1591-2 - PubMed
- Schizophr Res. 2004 Sep 1;70(1):49-56 - PubMed
- Schizophr Bull. 2007 Nov;33(6):1270-3 - PubMed
- Can J Psychiatry. 2002 Aug;47(6):527-37 - PubMed
- Neurosci Res. 2002 Aug;43(4):295-304 - PubMed
- Br J Psychiatry. 1979 Feb;134:169-77 - PubMed
- Epidemiology. 1999 Nov;10(6):747-51 - PubMed
- Am J Med Genet B Neuropsychiatr Genet. 2003 Jul 1;120B(1):1-10 - PubMed
- Am J Psychiatry. 2002 Sep;159(9):1528-33 - PubMed
- Am J Med Genet B Neuropsychiatr Genet. 2004 Jan 1;124B(1):6-9 - PubMed
- Eur Psychiatry. 2007 Jan;22(1):22-6 - PubMed
- Mol Psychiatry. 2004 Apr;9(4):358-70 - PubMed
- Arch Gen Psychiatry. 2007 Jan;64(1):14-6 - PubMed
- Schizophr Bull. 2003;29(1):169-78 - PubMed
- Arch Gen Psychiatry. 1989 Oct;46(10):867-72 - PubMed
- Am J Prev Med. 2004 Feb;26(2):178-85 - PubMed
- Schizophr Res. 2005 Jul 15;76(2-3):337-42 - PubMed
- Schizophr Res. 2004 Apr 1;67(2-3):227-36 - PubMed
- Br J Psychiatry. 2003 Nov;183:405-8 - PubMed
Publication Types